Insider Stock Trading History of Grillo Lopez Antonio J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Grillo Lopez Antonio J since year 2005. The trader's CIK number is 1235942. At the time of this reporting, Grillo Lopez Antonio J is the Director of Onyx Pharmaceuticals Inc . (stock ticker symbol ONXX). See this page for all insider trading activities at Onyx Pharmaceuticals Inc .

Note that in the past GRILLO LOPEZ ANTONIO J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Grillo Lopez Antonio J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-07-30 ONXX Onyx Pharmaceuticals Inc Sale 1,500 131.26 196,890
2013-07-26 ONXX Onyx Pharmaceuticals Inc Option Ex 2,000 76.79 153,580
2013-07-26 ONXX Onyx Pharmaceuticals Inc Sale 2,000 130.50 261,000
2013-07-01 ONXX Onyx Pharmaceuticals Inc Sale 3,000 132.63 397,890
2013-04-23 ONXX Onyx Pharmaceuticals Inc Option Ex 5,000 37.68 188,400
2013-04-23 ONXX Onyx Pharmaceuticals Inc Sale 5,000 101.28 506,400
2013-04-11 ONXX Onyx Pharmaceuticals Inc Option Ex 43,164 29.74 1,283,697
2013-04-11 ONXX Onyx Pharmaceuticals Inc Sale 43,164 97.30 4,199,857
2013-04-01 ONXX Onyx Pharmaceuticals Inc Option Ex 25,000 22.65 566,250
2013-04-01 ONXX Onyx Pharmaceuticals Inc Sale 25,000 90.91 2,272,825
2012-12-12 ONXX Onyx Pharmaceuticals Inc Sale 7,265 82.25 597,546
2008-11-25 FVRL Favrille Inc Sale 165,500 .03 4,965
2008-11-26 FVRL Favrille Inc Sale 103,933 .03 3,117
2007-11-02 FVRL Favrille Inc Buy 175,747 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grillo Lopez Antonio J (Director of Onyx Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.